
Join to view full profile
17 Main StSte 304Robbinsville, NJ 08691
Phone+1 609-415-3376
Fax+1 609-415-3377
Dr. Lauck is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGovern Medical School at UTHealthClass of 2021
Certifications & Licensure
OR State Medical License 2024 - Present
TN State Medical License 2026 - 2028
MO State Medical License 2024 - 2027
MS State Medical License 2026 - 2027
NJ State Medical License 2025 - 2027
American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Response to Newell et al's "commentary on 'DPP4 inhibitor use and skin cancer risk in type 2 diabetes'".Zaryab Alam, Kevin T Nguyen, Kyle C Lauck, Hamza Malick, Stanislav N Tolkachjov
Journal of the American Academy of Dermatology. 2026-08-01 - 1 citationsAlopecia after glucagon-like peptide-1 agonist therapy: A TriNetX Database active comparator retrospective cohort study.Kyle C Lauck, Areeba Ahmed, Stanislav N Tolkachjov
Journal of the American Academy of Dermatology. 2026-07-01 - Longitudinal risk of cutaneous squamous cell carcinoma development following PD-1 inhibitor therapy for melanoma: A retrospective TriNetX cohort study.Faria Nusrat, Kyle Lauck, Tara Jennings, Naomi Lawrence
Journal of the American Academy of Dermatology. 2026-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









